1. Home
  2. Chemical & Material
  3. Global Monensin (CAS 17090-79-8) Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Global Monensin (CAS 17090-79-8) Industry Outlook 2021: Overview, Opportunities, Key Companies and Forecast to 2027

Publication Month: Sep 2021 | No. of Pages: 134 Published By: GRD Survey
Single User License: US $ 3980
Corporate User License: US $ 7960

Executive Summary

According to GRD Survey data, the global Monensin (CAS 17090-79-8) market was valued at million US$ in 2020 and is expected to million US$ by the end of 2027, growing at a CAGR of % in the forecast period 2021 and 2027.

This report studies the Monensin (CAS 17090-79-8) market dynamics from angles such as new entries, mergers and acquisitions, fundings, exit and major technology breakthroughs. Market performance is evaluated through market size (value and volume) by players, regions, product types and end industries. This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.

Geographically, this report is segmented into several key regions, with sales, revenue, market share and growth Rate of Monensin (CAS 17090-79-8) in these regions, from 2016 to 2027, covering
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Italy, Spain and Russia, etc.)
Asia-Pacific (China, Japan, Korea, Southeast Asia, India, Australia)
South America (Brazil, Argentina, Colombia, etc.)
Middle East and Africa (Turkey, Saudi Arabia, South Africa, etc.)

Market Snapshot, By Product Type
10% Monensin
20% Monensin
40% Monensin

Market Snapshot, By Application
Cattle
Sheep
Chicken
Others

Market Snapshot, By Region:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Spain
Asia Pacific
China
Japan
Korea
Southeast Asia
India
Australia
Central & South America
Brazil
Argentina
Colombia
Middle East & Africa
Iran
South Africa
Israel
Turkey
Saudi Arabia

Main Market Players Analyzed in this report, including:
Zoetis
Virbac
Qilu Pharmaceutical
Phibro Animal Health
Merck Animal Health
Huvepharma
Elanco
Ceva Animal Health
CAHIC
Biok Biology
Bio Agri Mix
Baoxiang Feed Technology
Animate Animal Health
Agrihealth

The study objectives of this report are:
To study and analyze the global Monensin (CAS 17090-79-8) market size (value & volume) by company, key regions/countries, products and application, history data from 2016 to 2020, and forecast to 2027.
To understand industry structure of Monensin (CAS 17090-79-8) market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To identify the key global Monensin (CAS 17090-79-8) manufacturers and regional typical players, to define, describe and analyze their sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Monensin (CAS 17090-79-8) market with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Monensin (CAS 17090-79-8) submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Monensin (CAS 17090-79-8) are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

This report includes the estimation of market size in terms of value (million USD) and volume from top-down approach by analyzing major submarkets and their major driving factors, and verified from bottom-up approaches. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified from primary sources.

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders Considered in the study:
Raw material vendors
Distributors/traders/wholesalers/suppliers
Regulatory authorities, including government agencies and NGO
Commercial research & development (R&D) institutions
Importers and exporters
Government organizations, research organizations, and consulting firms
Trade/Industrial associations
End-use industries

Table of Contents

1 Market Definition & Scope
1.1 Definition & Scope
1.2 Monensin (CAS 17090-79-8) Product Specifications
1.3 Main Events (Entry, M&A, Exit, Technology and Capital Activity)
1.4 Global Monensin (CAS 17090-79-8) Market Performance and Outlook

2 Market Development Performance under COVID-19
2.1 Influencing Factors of Industry Development in the Next Five Years
2.1.1 Drivers
2.1.2 Restraints
2.1.3 Opportunities
2.2 Porter's Five Forces Analysis
2.3 Comparison of Alternatives and Monensin (CAS 17090-79-8)

3 Supply Chain and Manufacturing Cost Analysis
3.1 Supply Chain Analysis
3.2 Raw Materials and Key Suppliers Analysis
3.2.1 Raw Materials Introduction
3.2.1 Raw Materials Key Suppliers List
3.3 Monensin (CAS 17090-79-8) Sales Channel and Distributors Analysis
3.3.1 Monensin (CAS 17090-79-8) Sales Channel
3.3.2 Monensin (CAS 17090-79-8) Distributors
3.4 Key Buying Industries/Consumers
3.4.1 Major Buyers in Application One
3.4.2 Major Buyers in Application Two
3.4.1 Major Buyers in Application Three
3.5 Monensin (CAS 17090-79-8) Manufacturing Cost Structure Analysis

4 Market Segment: by Type
4.1 Monensin (CAS 17090-79-8) Type Introduction
4.1.1 10% Monensin
4.1.2 20% Monensin
4.1.3 40% Monensin
4.2 Global Monensin (CAS 17090-79-8) Sales by Type 2016-2021
4.3 Global Monensin (CAS 17090-79-8) Revenue by Type 2016-2021
4.4 Global Monensin (CAS 17090-79-8) Price by Type 2016-2021

5 Market Segment: by Application
5.1 Monensin (CAS 17090-79-8) Type Introduction
5.1.1 Cattle
5.1.2 Sheep
5.1.3 Chicken
5.1.3 Others
5.2 Global Monensin (CAS 17090-79-8) Sales by Application 2016-2021
5.3 Global Monensin (CAS 17090-79-8) Revenue by Application 2016-2021
5.4 Global Monensin (CAS 17090-79-8) Price by Application 2016-2021

6 Marke Segment: by Region
6.1 Global Monensin (CAS 17090-79-8) Market by Region
6.1.1 Global Monensin (CAS 17090-79-8) Sales by Regions
6.1.2 Global Monensin (CAS 17090-79-8) Revenue by Regions
6.2 North America Monensin (CAS 17090-79-8) Market 2016-2021
6.3 Europe Monensin (CAS 17090-79-8) Market 2016-2021
6.4 Asia Pacific Monensin (CAS 17090-79-8) Market 2016-2021
6.5 South America Monensin (CAS 17090-79-8) Market 2016-2021
6.6 Middle East and Africa Monensin (CAS 17090-79-8) Market 2016-2021

7 North America
7.1 North America Monensin (CAS 17090-79-8) Market by Country 2016-2021
7.1.1 North America Monensin (CAS 17090-79-8) Sales by Country
7.1.2 North America Monensin (CAS 17090-79-8) Revenue by Country
7.2 United States
7.3 Canada
7.4 Mexico

8 Europe
8.1 Europe Monensin (CAS 17090-79-8) Market by Country 2016-2021
8.1.1 Europe Monensin (CAS 17090-79-8) Sales by Country
8.1.2 Europe Monensin (CAS 17090-79-8) Revenue by Country
8.2 Germany
8.3 France
8.4 UK
8.5 Italy
8.6 Russia
8.7 Spain

9 Asia Pacific
9.1 Asia Pacific Monensin (CAS 17090-79-8) Market by Country 2016-2021
9.1.1 Asia Pacific Monensin (CAS 17090-79-8) Sales by Country
9.1.2 Asia Pacific Monensin (CAS 17090-79-8) Revenue by Country
9.2 China
9.3 Japan
9.4 Korea
9.5 Southeast Asia
9.6 India
9.7 Australia

10 South America
10.1 South America Monensin (CAS 17090-79-8) Market by Country 2016-2021
10.1.1 South America Monensin (CAS 17090-79-8) Sales by Country
10.1.2 South America Monensin (CAS 17090-79-8) Revenue by Country
10.2 Brazil
10.3 Argentina
10.4 Colombia

11 Middle East and Africa
11.1 Middle East and Africa Monensin (CAS 17090-79-8) Market by Country 2016-2021
11.1.1 Middle East and Africa Monensin (CAS 17090-79-8) Sales by Country
11.1.2 Middle East and Africa Monensin (CAS 17090-79-8) Revenue by Country
11.2 Turkey
11.3 Saudi Arabia
11.4 South Africa

12 Key Participants Company Information
12.1 Zoetis
12.1.1 Zoetis Company Information
12.1.2 Zoetis Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
12.1.3 Zoetis Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
12.1.4 Zoetis Key Development
12.2 Virbac
12.2.1 Virbac Company Information
12.2.2 Virbac Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
12.2.3 Virbac Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
12.2.4 Virbac Key Development
12.3 Qilu Pharmaceutical
12.3.1 Qilu Pharmaceutical Company Information
12.3.2 Qilu Pharmaceutical Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
12.3.3 Qilu Pharmaceutical Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
12.3.4 Qilu Pharmaceutical Key Development
12.4 Phibro Animal Health
12.4.1 Phibro Animal Health Company Information
12.4.2 Phibro Animal Health Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
12.4.3 Phibro Animal Health Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
12.4.4 Phibro Animal Health Key Development
12.5 Merck Animal Health
12.5.1 Merck Animal Health Company Information
12.5.2 Merck Animal Health Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
12.5.3 Merck Animal Health Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
12.5.4 Merck Animal Health Key Development
12.6 Huvepharma
12.6.1 Huvepharma Company Information
12.6.2 Huvepharma Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
12.6.3 Huvepharma Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
12.6.4 Huvepharma Key Development
12.7 Elanco
12.7.1 Elanco Company Information
12.7.2 Elanco Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
12.7.3 Elanco Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
12.7.4 Huvepharma Key Development
12.9 CAHIC
12.9.1 CAHIC Company Information
12.9.2 CAHIC Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
12.9.3 CAHIC Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
12.9.4 CAHIC Key Development
12.8 Ceva Animal Health
12.8.1 Ceva Animal Health Company Information
12.8.2 Ceva Animal Health Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
12.8.3 Ceva Animal Health Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
12.8.4 Ceva Animal Health Key Development
12.11 Bio Agri Mix
12.11.1 Bio Agri Mix Company Information
12.11.2 Bio Agri Mix Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
12.11.3 Bio Agri Mix Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
12.11.4 Bio Agri Mix Key Development
12.12 Baoxiang Feed Technology
12.12.1 Baoxiang Feed Technology Company Information
12.12.2 Baoxiang Feed Technology Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
12.12.3 Baoxiang Feed Technology Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
12.12.4 Baoxiang Feed Technology Key Development
12.13 Animate Animal Health
12.13.1 Animate Animal Health Company Information
12.13.2 Animate Animal Health Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
12.13.3 Animate Animal Health Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
12.13.4 Animate Animal Health Key Development
12.14 Agrihealth
12.14.1 Agrihealth Company Information
12.14.2 Agrihealth Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
12.14.3 Agrihealth Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
12.14.4 Agrihealth Key Development

13 Global Monensin (CAS 17090-79-8) Market Forecast by Region by Type and by Application
13.1 Global Monensin (CAS 17090-79-8) Sales, Revenue Forecast 2022-2027
13.2 Global Monensin (CAS 17090-79-8) Forecast by Regions
13.2.1 Global Monensin (CAS 17090-79-8) Sales Forecast by Region 2022-2027
13.2.2 Global Monensin (CAS 17090-79-8) Revenue Forecast by Region 2022-2027
13.3 Global Monensin (CAS 17090-79-8) Forecast by Type
13.3.1 Global Monensin (CAS 17090-79-8) Sales Forecast by Type 2022-2027
13.3.2 Global Monensin (CAS 17090-79-8) Revenue Forecast by Type 2022-2027
13.3.3 Global Monensin (CAS 17090-79-8) Price Forecast by Type 2022-2027
13.4 Global Monensin (CAS 17090-79-8) Forecast by Application
13.4.1 Global Monensin (CAS 17090-79-8) Sales Forecast by Application 2022-2027
13.4.2 Global Monensin (CAS 17090-79-8) Revenue Forecast by Application 2022-2027
13.4.3 Global Monensin (CAS 17090-79-8) Price Forecast by Application 2022-2027

14 Analyst Views and Conclusions
15 Methodology and Data Source
15.1 Methodology
15.2 Research Data Source
15.2.1 Secondary Data
15.2.2 Primary Data
15.2.3 Market Size Estimation
15.3 Legal Disclaimer


List of Tables

Table 1: Global Monensin (CAS 17090-79-8) Production Specifications
Table 2: Drivers in Monensin (CAS 17090-79-8) Market
Table 3: Restraints Monensin (CAS 17090-79-8) Market
Table 4: Opportunity in Monensin (CAS 17090-79-8) Market
Table 5: Comparion of Alternative and Monensin (CAS 17090-79-8)
Table 6: Monensin (CAS 17090-79-8) Raw Materials Key Suppliers List
Table 7: Monensin (CAS 17090-79-8) Distributors List
Table 8: Monensin (CAS 17090-79-8) Major Buyers in Application One
Table 9: Monensin (CAS 17090-79-8) Major Buyers in Application Two
Table 10: Monensin (CAS 17090-79-8) Major Buyers in Application Three
Table 11: Global Monensin (CAS 17090-79-8) Sales (K Units) by Type 2016-2021
Table 12: Global Monensin (CAS 17090-79-8) Sales Market Share by Type 2016-2021
Table 13: Global Monensin (CAS 17090-79-8) Revenue (Million USD) by Type 2016-2021
Table 14: Global Monensin (CAS 17090-79-8) Revenue Market Share by Type 2016-2021
Table 15: Global Monensin (CAS 17090-79-8) Price by Type 2016-2021
Table 16: Global Monensin (CAS 17090-79-8) Sales (K Units) by Application 2016-2021
Table 17: Global Monensin (CAS 17090-79-8) Sales Market Share by Application 2016-2021
Table 18: Global Monensin (CAS 17090-79-8) Revenue (Million USD) by Application 2016-2021
Table 19: Global Monensin (CAS 17090-79-8) Revenue Market Share by Application 2016-2021
Table 20: Global Monensin (CAS 17090-79-8) Price by Application 2016-2021
Table 21: Global Monensin (CAS 17090-79-8) Sales (K Units) by Region 2016-2021
Table 22: Global Monensin (CAS 17090-79-8) Sales Market Share by Region 2016-2021
Table 23: Global Monensin (CAS 17090-79-8) Revenue (Million USD) by Region 2016-2021
Table 24: Global Monensin (CAS 17090-79-8) Revenue Market Share by Region 2016-2021
Table 25: North America Monensin (CAS 17090-79-8) Sales (K Units) by Country 2016-2021
Table 26: North America Monensin (CAS 17090-79-8) Sales Market Share by Country 2016-2021
Table 27: North America Monensin (CAS 17090-79-8) Revenue (Million USD) by Country 2016-2021
Table 28: North America Monensin (CAS 17090-79-8) Revenue Market Share by Country 2016-2021)
Table 29: Europe Monensin (CAS 17090-79-8) Sales (K Units) by Country 2016-2021
Table 30: Europe Monensin (CAS 17090-79-8) Sales Market Share by Country 2016-2021
Table 31: Europe Monensin (CAS 17090-79-8) Revenue (Million USD) by Country 2016-2021
Table 32: Europe Monensin (CAS 17090-79-8) Revenue Market Share by Country 2016-2021)
Table 33: Asia Pacific Monensin (CAS 17090-79-8) Sales (K Units) by Country 2016-2021
Table 34: Asia Pacific Monensin (CAS 17090-79-8) Sales Market Share by Country 2016-2021
Table 35: Asia Pacific Monensin (CAS 17090-79-8) Revenue (Million USD) by Country 2016-2021
Table 36: Asia Pacific Monensin (CAS 17090-79-8) Revenue Market Share by Country 2016-2021)
Table 37: South America Monensin (CAS 17090-79-8) Sales (K Units) by Country 2016-2021
Table 38: South America Monensin (CAS 17090-79-8) Sales Market Share by Country 2016-2021
Table 39: South America Monensin (CAS 17090-79-8) Revenue (Million USD) by Country 2016-2021
Table 40: South America Monensin (CAS 17090-79-8) Revenue Market Share by Country 2016-2021)
Table 41: Middle East and Africa Monensin (CAS 17090-79-8) Sales (K Units) by Country 2016-2021
Table 42: Middle East and Africa Monensin (CAS 17090-79-8) Sales Market Share by Country 2016-2021
Table 43: Middle East and Africa Monensin (CAS 17090-79-8) Revenue (Million USD) by Country 2016-2021
Table 44: Middle East and Africa Monensin (CAS 17090-79-8) Revenue Market Share by Country 2016-2021)
Table 45 Zoetis Company Information
Table 46 Zoetis Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
Table 47 Zoetis Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 48 Virbac Company Information
Table 49 Virbac Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
Table 50 Virbac Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 51 Qilu Pharmaceutical Company Information
Table 52 Qilu Pharmaceutical Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
Table 53 Qilu Pharmaceutical Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 54 Phibro Animal Health Company Information
Table 55 Phibro Animal Health Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
Table 56 Phibro Animal Health Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 57 Merck Animal Health Company Information
Table 58 Merck Animal Health Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
Table 59 Merck Animal Health Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 60 Huvepharma Company Information
Table 61 Huvepharma Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
Table 62 Huvepharma Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 63 Elanco Company Information
Table 64 Elanco Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
Table 65 Elanco Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 66 Ceva Animal Health Company Information
Table 67 Ceva Animal Health Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
Table 68 Ceva Animal Health Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 69 CAHIC Company Information
Table 70 CAHIC Monensin (CAS 17090-79-8) Product Portfolio, Specification and Application
Table 71 CAHIC Monensin (CAS 17090-79-8) Sales, Price, Revenue and Gross Margin (2019-2021)
Table 72: Global Monensin (CAS 17090-79-8) Sales (K Units) Forecast by Region (2022-2027)
Table 73: Global Monensin (CAS 17090-79-8) Sales Market Share Forecast by Region (2012-2027)
Table 74: Global Monensin (CAS 17090-79-8) Revenue (Million USD) Forecast by Region (2022-2027)
Table 75: Global Monensin (CAS 17090-79-8) Revenue Market Share Forecast by Region (2022-2027)
Table 76: Global Monensin (CAS 17090-79-8) Sales (K Units) Forecast by Type (2022-2027)
Table 77: Global Monensin (CAS 17090-79-8) Sales Market Share Forecast by Type (2012-2027)
Table 78: Global Monensin (CAS 17090-79-8) Revenue (Million USD) Forecast by Type (2022-2027)
Table 79: Global Monensin (CAS 17090-79-8) Revenue Market Share Forecast by Type (2022-2027)
Table 80: Global Monensin (CAS 17090-79-8) Sales (K Units) Forecast by Applicaion (2022-2027)
Table 81: Global Monensin (CAS 17090-79-8) Sales Market Share Forecast by Application (2012-2027)
Table 82: Global Monensin (CAS 17090-79-8) Revenue (Million USD) Forecast by Application (2022-2027)
Table 83: Global Monensin (CAS 17090-79-8) Revenue Market Share Forecast by Application (2022-2027)

Tables and Figures

List of Figures

Figure 1: Monensin (CAS 17090-79-8) Picture
Figure 2: Global Monensin (CAS 17090-79-8) Market Size (Million USD) and Growth Rate (2016-2027)
Figure 3: Porter's Five Forces Analysis
Figure 4: Monensin (CAS 17090-79-8) Supply Chain Analysis
Figure 5: Monensin (CAS 17090-79-8) Manufacturing Cost Structure Analysis
Figure 6: Product Picture of 10% Monensin
Figure 7: Product Picture of 20% Monensin
Figure 8: Global Monensin (CAS 17090-79-8) Sales Market Share by Type, 2020
Figure 9: Global Monensin (CAS 17090-79-8) Revenue Market Share by Type, 2020
Figure 10: Monensin (CAS 17090-79-8) in Cattle
Figure 11: Global Monensin (CAS 17090-79-8) Market: Cattle 2016-2021
Figure 12: Monensin (CAS 17090-79-8) in Sheep
Figure 13: Global Monensin (CAS 17090-79-8) Market: Sheep 2016-2021
Figure 14: Global Monensin (CAS 17090-79-8) Sales Market Share by Application, 2020
Figure 15: Global Monensin (CAS 17090-79-8) Revenue Market Share by Application, 2020
Figure 16: Global Monensin (CAS 17090-79-8) Sales Market Share by Region 2016-2021
Figure 17: Global Monensin (CAS 17090-79-8) Revenue Market Share by Region 2016-2021
Figure 18: North America Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 19: North America Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 20: Europe Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 21: Europe Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 22: Asia Pacific Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 23: Asia Pacific Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 24: South America Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 25: South America Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 26: Middle East and Africa Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 27: Middle East and Africa Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 28: North America Monensin (CAS 17090-79-8) Sales Market Share by Country, 2020
Figure 29: North America Monensin (CAS 17090-79-8) Revenue Market Share by Country, 2020
Figure 30: United States Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 31: United States Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 32: Canada Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 33: Canada Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 34: Mexico Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 35: Mexico Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 36: Europe Monensin (CAS 17090-79-8) Sales Market Share by Country, 2020
Figure 37: Europe Monensin (CAS 17090-79-8) Revenue Market Share by Country, 2020
Figure 38: Germany Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 39: Germany Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 40: France Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 41: France Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 42: UK Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 43: UK Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 44: Italy Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 45: Italy Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 46: Russia Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 46: Russia Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 47: Spain Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 48: Spain Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 49: Asia Pacific Monensin (CAS 17090-79-8) Sales Market Share by Country, 2020
Figure 50: Asia Pacific Monensin (CAS 17090-79-8) Revenue Market Share by Country, 2020
Figure 51: China Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 52: China Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 53: Japan Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 54: Japan Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 55: Korea Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 56: Korea Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 57: Southeast Asia Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 58: Southeast Asia Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 59: India Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 60: India Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 61: Australia Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 62: Australia Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 63: South America Monensin (CAS 17090-79-8) Sales Market Share by Country, 2020
Figure 64: South America Monensin (CAS 17090-79-8) Revenue Market Share by Country, 2020
Figure 65: Brazil Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 66: Brazil Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 67: Argentina Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 68: Argentina Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 69: Colombia Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 70: Colombia Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 71: Middle East and Africa Monensin (CAS 17090-79-8) Sales Market Share by Country, 2020
Figure 72: Middle East and Africa Monensin (CAS 17090-79-8) Revenue Market Share by Country, 2020
Figure 73: Turkey Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 74: Turkey Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 75: Saudi Arabia Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 76: Saudi Arabia Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 77: South Africa Monensin (CAS 17090-79-8) Sales (K Units) Status 2016-2021
Figure 78: South Africa Monensin (CAS 17090-79-8) Revenue (Million USD) Status 2016-2021
Figure 79: Zoetis Monensin (CAS 17090-79-8) Revenue Market Share Globally (2019-2021)
Figure 80: Virbac Monensin (CAS 17090-79-8) Revenue Market Share Globally (2019-2021)
Figure 81: Qilu Pharmaceutical Monensin (CAS 17090-79-8) Revenue Market Share Globally (2019-2021)
Figure 82: Phibro Animal Health Monensin (CAS 17090-79-8) Revenue Market Share Globally (2019-2021)
Figure 83: Merck Animal Health Monensin (CAS 17090-79-8) Revenue Market Share Globally (2019-2021)
Figure 84: Huvepharma Monensin (CAS 17090-79-8) Revenue Market Share Globally (2019-2021)
Figure 85: Elanco Monensin (CAS 17090-79-8) Revenue Market Share Globally (2019-2021)
Figure 86: Ceva Animal Health Monensin (CAS 17090-79-8) Revenue Market Share Globally (2019-2021)
Figure 87: CAHIC Monensin (CAS 17090-79-8) Revenue Market Share Globally (2019-2021)
Figure 88: Biok Biology Monensin (CAS 17090-79-8) Revenue Market Share Globally (2019-2021)
Figure 89: Global Monensin (CAS 17090-79-8) Sales (K Units) Forecast (2022-2027)
Figure 90: Global Monensin (CAS 17090-79-8) Sales (K Units) Forecast (2022-2027)


Reason to Buy

  • Current and future of Chemical & Material Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Chemical & Material Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Chemical & Material Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Chemical & Material Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets